TransDermal Technologies, Inc. – Trademark Portfolio
Entity Type: 03
TransDermal Technologies, Inc. has 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include PENETRAN. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 1 (Chemicals) and Class 3 (Cosmetics & Cleaning). This trademark owner is based in LAKE PARK, FL.
1368 N KILLIAN DRIVE
LAKE PARK, FL 33403
Showing of trademarks Trademarks
Trademark Classifications
TransDermal Technologies, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does TransDermal Technologies, Inc. have?
TransDermal Technologies, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 3 cancelled.
What trademark classes does TransDermal Technologies, Inc. file in?
TransDermal Technologies, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are TransDermal Technologies, Inc.'s most well-known trademarks?
TransDermal Technologies, Inc.'s registered trademark portfolio includes well-known marks such as PENETRAN. These are among 1 currently registered trademark in the portfolio.
What is TransDermal Technologies, Inc.'s trademark registration success rate?
TransDermal Technologies, Inc. has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.